Profiles

Charles Keller

Scientific Director, Children's Cancer Therapy Development Institute

Verified email at cc-tdi.org

Cited by 10576

childhood cancer rhabdomyosarcoma sarcoma medulloblastoma dipg

David S Ziegler

Sydney Children's Hospital

Verified email at unsw.edu.au

Cited by 6711

Childhood cancer brain tumours DIPG early phase clinical trials

Timothy N Phoenix

Associate Professor, University of Cincinnati

Verified email at uc.edu

Cited by 4446

Neuro-Oncology Pediatric brain tumors DIPG Blood-brain barrier

Matthew D. Dun

Professor of Paediatric Haematology/Oncology Research, NHMRC Investigator, College …

Verified email at newcastle.edu.au

Cited by 3768

DIPG DMG Leukemia Proteogenomics Cell Signaling

Nicholas A. Vitanza

Associate Professor - Laboratory PI - CNS CAR T cell Lead - DIPG Research Lead, Seattle …

Verified email at seattlechildrens.org

Cited by 2718

Pediatric Neuro-Oncology DIPG DMG CAR T cells

Maria Tsoli

Children's Cancer Institute

Verified email at ccia.org.au

Cited by 2664

Brain Tumours DIPG HTS PDX development Personalised Medicine

Ranjith Jayaraman PhD

Postdoctoral Research Fellow, Cancer Signalling Research Group, University of Newcastle

Verified email at newcastle.edu.au

Cited by 545

Immunotherapy Tumour immune microenvironment Immune checkpoint inhibitors DMG DIPG

Harpreet Kaur

Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center

Verified email at jhmi.edu

Cited by 545

Adult and Pediatric Neuro-Oncology (GBM DIPG ATRT) Cancer stem cells Tumor invasion

Zeinab Mamdouh

PhD student, Pharmacology and personalised medicine department, Maastricht University …

Verified email at ppmlab.net

Cited by 495

Network Pharmacology Drug Repurposing Disease modules Thyroid cancer DIPG

Abdul Mannan

Postdoctoral researcher, The University of Newcastle

Verified email at newcastle.edu.au

Cited by 299

Cancer biology Leukaemia cell culture PDX model DIPG

1 - 10